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Abstract
Background: Our objective was to determine the impacts of artificial intelligence (AI) on public health practice.
Methods: We used a fundamental qualitative descriptive study design, enrolling 15 experts in public health and AI
from June 2018 until July 2019 who worked in North America and Asia. We conducted in-depth semi-structured
interviews, iteratively coded the resulting transcripts, and analyzed the results thematically.
Results: We developed 137 codes, from which nine themes emerged. The themes included opportunities such as
leveraging big data and improving interventions; barriers to adoption such as confusion regarding AI’s applicability,
limited capacity, and poor data quality; and risks such as propagation of bias, exacerbation of inequity, hype, and
poor regulation.
Conclusions: Experts are cautiously optimistic about AI’s impacts on public health practice, particularly for
improving disease surveillance. However, they perceived substantial barriers, such as a lack of available expertise,
and risks, including inadequate regulation. Therefore, investment and research into AI for public health practice
would likely be beneficial. However, increased access to high-quality data, research and education regarding the
limitations of AI, and development of rigorous regulation are necessary to realize these benefits.
Keywords: Population health, Preventive medicine, Machine learning, Community medicine, Big data,
Epidemiology, Qualitative
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: piggott@mcmaster.ca
1Department of Health Research Methods, Evidence, and Impact, McMaster
University, Hamilton, Ontario, Canada
Full list of author information is available at the end of the article
Morgenstern et al. BMC Public Health           (2021) 21:40 
https://doi.org/10.1186/s12889-020-10030-x
Background
After more than 60 years of evolution as a field [1], arti-
ficial intelligence (AI) has become ubiquitous in the last
decade. These changes have prompted both excitement
and trepidation regarding potential impacts in virtually
all human endeavours, including public health. Interest-
ingly, despite widespread discussion, there is no univer-
sally accepted definition of AI. One definition, offered by
Kaplan and Haenlein, describes AI as “a system’s ability
to interpret external data correctly, to learn from such
data, and to use those learnings to achieve specific goals
and tasks through flexible adaptation.” [2] Cybernetics
researchers developed some of the first AI systems, in-
cluding designs for an artificial neuron in 1943 [1]. The
AI-term was adopted by the field following a workshop
in 1956 [1]. In the ensuing years, AI research went
through several boom and bust cycles, including a focus
on rules-based expert systems in the 1970s and -80s [3].
In the early 2000s, increasing computational power, the
ability to record and access vast amounts of data, and
several enabling theoretical developments encouraged a
renewed focus on data-driven approaches to AI [1].
Many of these approaches fall under the subfield of ma-
chine learning, which can be loosely defined as a “field
of study that gives computers the ability to learn without
being explicitly programmed.” [4] Machine learning
forms the foundation for most modern applications of
AI, including targeted online advertising, conversational
AI-assistants, and movie recommendations. These ap-
proaches are data-hungry, often relying on big data, or
information flows with abundant volume, velocity, and
variety [5].
Beyond the most visible applications of AI among the
tech giants of Silicon Valley, it has started to infiltrate
healthcare and public health. In healthcare, AI applica-
tions have been reported that match or outperform
physicians in various domains including radiology [6],
dermatology [7], and pathology [8]. Additionally, some
hospitals have begun to integrate AI into the clinical
workflow, as in the case of New York University Lan-
gone Health’s predictive analytics unit [9]. While consid-
erable attention has been paid to AI in healthcare, there
has been less attention on its impact in public health
[10]. Despite this, public health researchers and practi-
tioners have begun applying AI to diverse projects such
as scanning the internet for nascent outbreaks [11], pre-
dicting suicide using electronic health records [12], and
identifying risk factors [13]. As such, there has been
growing optimism regarding the potential for AI to im-
prove public health [14]; however, few AI systems have
actually been implemented within public health organi-
zations. Moving forward, there are serious concerns
regarding AI’s impacts on privacy, interpretability, and
potential for bias [15, 16]. Also, there has been criticism
that AI as applied in precision public health is merely
scaling up the precision medicine approach [17]. The
potential to move beyond biomedical applications of AI
to models incorporating rich characterizations of the
social determinants of health has been identified as a
promising and largely unexplored frontier. A clearer un-
derstanding of AI’s relevance to public health, which is
presently absent from the literature, is needed to navi-
gate the opportunities and risks. We conducted an initial
step towards filling this gap by examining the perspec-
tives of experts in public health and AI regarding impli-
cations of AI for public health practice.
Methods
We used a fundamental qualitative descriptive study
design [18] to explore the impacts of AI on public health
practice (see Additional file 1 for the consolidated criteria
for reporting qualitative research (COREQ) checklist). We
conducted in-depth semi-structured interviews with
experts in public health and/or artificial intelligence. We
selected participants using a mixed sampling strategy. A
thematic analysis underlies our conclusions. The project
was approved by the Hamilton Integrated Research Ethics
Board (Project #: 4825).
Participant recruitment
We sampled contributors from a pool of experts in pub-
lic health and artificial intelligence using a combination
of convenience, snowball, and stratified purposeful sam-
pling [19]. This included identifying participants known
to us, known to interviewees, and performing internet
searches. We selected prospective interviewees to repre-
sent a range of perspectives, including academia, govern-
ment, industry, and non-governmental organizations
(NGOs); a range of disciplines, including public health
physicians, epidemiologists, computer scientists, and
policy-experts; and a range of contexts, including high-
income and low-income countries.
We initially contacted all participants with a standard
email invitation. If we did not receive a response, we
sent a single follow-up email after 1 week but made no
further efforts to contact prospective participants. We
answered interested invitees’ questions and emailed
them a consent form. We received written consent to
participate.
Semi-structured interviews
We developed an interview guide to support the semi-
structured interview process, which was pilot tested (see
Additional file 2 for interview guide). This guide was based
on the essential public health functions developed by the
Pan-American Health Organization [20]. Functions in-
clude examples such as “monitoring, evaluation, and ana-
lysis of health status”, “health promotion”, and “research
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in public health”. We framed interview questions around
AI’s impact on essential public health functions, as well as
several current issues in public health. In addition to pre-
specified interview questions, we followed up on statements
made by interviewees [21]. Also, we focused on domains
most related to the interviewee’s expertise. Therefore, we
asked different questions with each interviewee.
At the beginning of each interview we discussed the
consent form, answered questions, and obtained and ar-
chived a signed copy of the form (see Additional file 3
for a description of the interviewers). No one except for
the interviewer(s) and interviewee were present. We
conducted interviews once with each participant either
over the phone or in-person (depending on the inter-
viewee’s preference) and recorded them. We stored the
recordings in an encrypted, password-protected folder.
Field notes were made during and after interviews.
We conducted fifteen interviews, which is consistent
with the number collected in comparable studies [21].
Additionally, we verified that fewer new codes were gen-
erated in later interviews, indicating relative saturation
(see results). However, given the broad area of inquiry,
absolute saturation could not be guaranteed. We tran-
scribed the interviews using Descript [22], an automated
transcription program. Then, we manually edited and
de-identified transcripts. Transcripts were only viewed
by the researchers.
Coding and thematic analysis
Following transcription and de-identification, we imported
transcripts into an encrypted project within Dedoose [23],
a mixed-methods research data-processing program.
Then, two investigators iteratively created codes used to
categorize components of each transcript. Following initial
coding, we conducted a three-stage process to generate
themes. First, two investigators independently identified
five initial themes, which were compared. Then, we identi-
fied and discussed topics and themes from each interview.
Lastly, we identified the most-used codes and iteratively
combined them into themes. We collated the results of
each stage into the list of themes.
Following initial thematic analysis, we re-organized
and condensed the codes. Additionally, we reviewed the
transcripts to identify key quotes related to identified
themes. Throughout this process, we continued to refine
themes until reaching consensus. Participants did not
provide feedback on findings.
Word cloud
We built a word cloud of the study codes using Wor-
dArt [24] software. The number of applications of each
code determined its size in the word cloud. The word
cloud excludes the most general root-codes.
Results
Of the 25 interview invitees, 7 (28%) did not respond
and 3 (12%) declined to participate. In all cases when
the interview was declined, the reason given was that
prospective participants were overwhelmed with their
responsibilities. The fifteen conducted interviews had a
median duration of 45 min.
Table 1 shows the participants’ characteristics. Ap-
proximately one quarter of the participants were female.
Most respondents’ primary expertise was in epidemi-
ology, medicine, or public health; however, all had
significant experience or interest in AI. Participants dif-
fered widely in career stage and age.
We developed 135 codes, which were applied 572
times to 377 excerpts. The number of new codes gener-
ated decreased over time, with interviews 13, 14, and 15
producing three, two, and zero new codes respectively.
The coding system included 3 levels of nested codes,
with most in the second level. The major root-codes
were Opportunities, Barriers, Threats, and Hype. Includ-
ing sub-codes, we used the Opportunities root-code the
most, a total of 188 times. We applied Barrier codes 126
times and Threats codes 62 times. See Fig. 1 for a word
cloud of the codes used and Additional file 4 for a table
containing detailed coding information.
Thematic analysis
Nine themes emerged (See Table 2). A description of
each theme, including key quotes, follows.
From big data to big insights
The potential for AI to convert big data into actionable
public health insights was a major focus of discussion.
Many experts emphasized that public health has always
Table 1 Participant characteristics




North America 14 (93.3%)




Non-governmental Organization 2 (13.3%)
Primary Area of Expertise
Artificial Intelligence 2 (13.3%)
Epidemiology 3 (20%)
Medicine 3 (20%)
Public Health 7 (46.7%)
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been very data-driven, but that AI could expand these
activities even further.
The broad implications of AI for public health are
that AI can serve as an intermediary between the
huge amounts of data that we generate and action.
[Participant ID # 4] (see Additional file 5 for
characteristics associated with each participant ID).
Specifically, interviewees highlighted surveillance as a
top domain of public health for AI applications (see
Additional file 6 for further supporting quotations). AI’s
ability to use novel data sources for extracting meaning-
ful public health information from unstructured data
sources was considered a major advantage, that could
supplement traditional disease surveillance.
You know, our traditional approaches, analysis,
regression, so on work with structured data and
you can work with even large amounts of structured
data[…] But when you’re talkin’ about data that’s
coming, and, again, you can think of all these sorts of
unstructured data from large numbers of people …
Like, basically if you look at that raw data every
second of your day... There’s a record for that.
Um, you can’t analyze that with traditional
methods, and you don’t necessarily want to,
right? So, you need tools [like AI] that will take
one individual’s data [and] turn it into something
meaningful. And then you’ve got millions of people’s
worth of data.
[Participant ID # 7].
One example pointed out by participants, HealthMap
[11], uses a combination of official and unofficial online,
unstructured data sources for disease surveillance (see
Additional file 6).
In addition to making use of novel sources of data,
participants pointed out that AI could allow us to per-
form disease surveillance in a more timely and ongoing
fashion.
… looking at things like mortality data. We’ve had a
very significant lag. It gets coded, it gets cleaned, it
gets deposited at the provincial or national level.
The data can be a year or two out of date. […] With
Fig. 1 A word cloud of the study codes, excluding the most general root-codes. The size of each code reflects the number of times that it was applied.
Table 2 Themes identified
Opportunities Themes Barriers Themes Risks Themes
• From Big Data to Big Insights
• AI Will Improve Public Health Interventions
• What is AI for?
• Limited Capacity
• Lack of Quality Data
• Bias Must be Controlled
• Uncertain Impact on Inequity
• Hold the Hype
• Rigorous Regulation Required
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some of these [AI] tools we are going to have the
opportunity to really accelerate and for the first
time have population-based data in real time.
[Participant ID # 9].
An example highlighted by respondents entailed
using hospital triage data for real-time surveillance
(see Additional file 6).
Better use of large, linked datasets for both disease
surveillance and exploratory analyses is another oppor-
tunity identified by participants.
It’s difficult to think of the dataset that wouldn’t
potentially have relevance to public health. And
this is the point when we start doing these big
data fusion exercises, you often find that the
most interesting, informative dataset is one you’ve
never thought of. You just threw it in there because
you had access to it.
[Participant ID # 4].
Experts pointed to a platform being piloted that uses a
sophisticated ontology to integrate administrative health
data, health survey data, and electronic medical records
data, while also automatically providing evidence-informed
population health priorities, causal information, and applic-
able preventive interventions (see Additional file 6).
In a related sense, experts pointed out that AI may
prove capable of sifting through big data to facilitate
knowledge translation broadly, as well as the creation of
guidelines (see Additional file 6).
Beyond improving existing disease surveillance
systems, it was thought that AI might allow leapfrog-
ging in places lacking traditional infrastructure. In so
doing, AI could enable earlier and more effective
control of burgeoning epidemics.
… there [are] a lot of places in the world where
there is absolutely no public health infrastructure
whatsoever and when things kick off there, that’s
where you start to get your […] Ebola outbreaks or
your Zika virus outbreaks. […] I picture [AI] as
being […] an easy sort of tractable way to get
surveillance into places where spillover events,
where emerging infections are likely to kind of pop up
and where they would otherwise generally go missed
due to a lack of laboratories and infrastructure.
[Participant ID # 6].
AI will improve public health interventions
Participants affirmed AI’s potential to advance public
health interventions, including screening for diseases
where it may sometimes already exceed human perform-
ance (see Additional file 6).
In addition to automating existing screening pro-
grams, AI may make entirely new forms of screening
feasible.
I think the cost of these technologies is going to
continue to come down. So, I don’t want to get too
sci-fi, but you could imagine a future where everyone’s
got a device of some type. […] So cheap that the
government actually provides everyone with a
personal health monitor.
[Participant ID # 7].
Experts also thought that AI’s ability to better leverage
real-time insights from big data may facilitate nearly in-
stantaneous design and enactment of preventive inter-
ventions, creating a much nimbler loop of learning and
action.
I think [AI’s] also going to enable us to design and
implement interventions in real-time. So, to be able
to do like […] internet companies[, who] will do A/
B testing on the color of that button that you got
right there and see which one people are more
responsive to. We can start to think about [similar
real-time interventions] in public health. Uh, can we
go into supermarkets and change the way in which
signs around vegetables are presented, and monitor
cash register data in real-time. So, you can design
health promotion interventions in real time.
[Participant ID # 7].
Some interviewees went on to suggest that these real-
time AI interventions could be used for more personal-
ized health promotion, particularly through using social
media information.
You’ll probably be accused of nanny state-type
intervention, but, you know, every time you see
someone eating a cheeseburger and French fries on
their [social media platform] you say, ‘Hey, [ …]
how about some vegetables?’
[Participant ID # 4].
Rather than simply personalizing health promotion, it
was proposed that we might apply social networking
models to target public health messaging for maximal
impact.
… machine learning plays a critical role in sort of
identifying where your opportunities are to influence
and, you know, if I look at who’s following whom on
[social media], I actually only need to influence four
people and now I can influence 400,000.
[Participant ID # 4].
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However, not all respondents thought there was great
potential for more adaptive and targeted health promo-
tion interventions (see Additional file 6).
What is AI for?
Beyond leveraging big data and improving interventions,
experts were in less agreement regarding AI’s applica-
tions. Some thought that AI’s greatest potential lies in
causal inference and hypothesis generation.
What are the factors that contribute to drowning in
[the] beach? [You] look for similarities, patterns,
trends that were not anything that would have been
[previously] comprehended because people would
focus on, you know, they couldn’t swim or they
didn’t have life jackets. But it may be that they all
have congenital heart disease. Again, not likely […],
but you’re getting my drift.
[Participant ID # 9].
In contrast, other interviewees thought that AI has lit-
tle potential for identifying novel causes.
… we’re not going to discover new risk factors. I
don’t believe that. I don’t believe these methods are
going to reveal risks for sub-populations that we
don’t already know.
[Participant ID # 12].
Indeed, the interpretability of machine learning algo-
rithms is widely considered to be an issue. Many AI
methods, especially deep learning, are considered inscrut-
able. However, some participants thought that these issues
could be overcome.
I mean the two hottest research areas in machine
learning and AI right now are explainability and
causal reasoning. So, I think there is a huge demand
from many, many, many perspectives to be better
able to explain those things and to be, um, you
know, to be able to learn causal association. Or
causal, you know factors. […] My sense is we’ll get
better at it. I don’t know if it’ll ever get perfect with
the really, truly data-driven methods, but I think
we’ll see big improvements in the next few years.
[Participant ID # 3].
Despite the potential for increasingly interpretable AI,
it is more commonly applied to predictive analytics.
Some interviewees thought that this will be an important
application for public health (see Additional file 6).
However, even for prediction applications experts point
to difficulties in knowing when to use AI approaches,
which are often considered much more flexible than
standard regression techniques.
… the question then becomes is the extra information
that comes from loosening [the model] up actually
valuable and useful? That’s what we need to still
figure out. We don’t have a good handle on that
yet. But I think we will. […] And then we can
refine our efforts at focusing on those specific
places instead of just saying, oh we need to just
[…] neural network everything.
[Participant ID # 12].
Limited capacity
Many respondents identified barriers to applying AI in
public health, such as limited availability of AI expertise
and a lack of leadership on it in public health.
Right now, it’s hard to see that drive coming from
within public health and […] it’s hard to see it […]
coming from the AI community because there’s so
many more low-hanging fruits that are […] competing
for their attention right now.
[Participant ID # 3].
It was thought that cross-training of those with public
health expertise, including medical students who become
public health physicians, would be helpful.
They need to be exposed to, here’s really basic high-
level intuition of how machine learning works.
Here’s what the tools can do for you as a physician
whether you become a radiologist or public health
physician. And here are some examples of how
they’re applied. And that’s really all you can do.
[Participant ID # 4].
Experts also thought that hiring staff with dedicated
AI expertise was important, but noted it was difficult to
compete with industry and more healthcare-oriented
sectors (see Additional file 6).
… if you need talent to do stuff like this, you’re
competing with industry offering […] eye watering
salaries.
[Participant ID # 4].
And while participants had found significant interest
in AI applications for public health from decision-
makers, it was difficult to obtain the financial support
needed to innovate.
All of that sort of technical and brain power stuff
that’s been tough for me to get, um, because I have
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no money. I have no money or no resources, so I’m
trying to build relationships to get us to do that. So,
the government in themselves have not been able to
get me there. They like the concepts. Everybody
agrees with the concepts. All the big people agree
with the concepts. It’s delivering it.
[Participant ID # 9].
Lack of quality data
Experts frequently emphasized that most AI approaches
are predicated on access to clean, high-quality data,
which can be difficult to find for health applications.
… the fuel for artificial intelligence is data and the
state of data, of health-related data right now is...
It’s pretty dismal.
[Participant ID # 13].
For example, while there has been significant interest
in using AI to leverage clinical notes in electronic med-
ical records (EMRs) for disease surveillance, the quality
of this data is a concern.
I must say I’m not overly optimistic of the value of
[applying natural language processing to EMRs].
[…] I’m not [sure] what you get out of there that’s
not already in structured format [and] that you can
do consistently in a repeatable manner. […] It’s
going to be highly variable depending on the
EMR. […] I think it’s a value but […] I think it’s
a big heavy job to do it across multiple EMRs
and the [whole region] and do a good job of it.
[Participant ID # 3].
Increased standardization was suggested to improve
the usability of health data and the potential for linkage
among various datasets (see Additional file 6).
Privacy concerns were acknowledged as another
concern when obtaining data for public health
purposes.
Yeah, some hospitals, their privacy officers are just
so concerned. There’s such a fear now of, you know,
the potential for re-identification and privacy.
Sometimes it’s about the time and resources for
them to come on. It’s about risk and liability and it’s
really unfortunate. We’ve done like just so much
work. We’ve spent so many hours. We’ve had legal
counsel involved. Uh, just to overcome privacy
concerns. Yeah, it’s quite an issue.
[Participant ID # 8].
Some thought that privacy concerns among adminis-
trators, lawmakers, and scientists may not realistically
reflect citizens’ concerns.
… the public are a lot savvier than we give them
credit for and people are very good at distinguishing
between corporations use of data for […] targeting
advertising […] versus […] medical and scientific
use of data to improve peoples’ health. […] We
often are afraid that we’re going to be painted with
the same brush that people paint […] [social media
companies or political consulting firms, thinking
that] if we use anything to do with that and if we
even say the word data people are going to get really
angry.
[Participant ID # 6].
Finally, many datasets of interest to public health are
owned by private companies, making their use difficult.
[This computer’s company’s] got data, [that
wearable company’s] got data, there’s other firms
that have... [This sporting goods company’s] got
their systems, right. So, everyone’s got their systems.
And there’s really no way for public health, if we felt
we wanted to use that for surveillance purposes, we
would have to go out and negotiate with each one.
[Participant ID # 7]
Bias must be controlled
Participants were concerned about the potential for AI
to propagate social and cognitive biases that can become
part of the datasets used by AI algorithms for training.
… data and algorithms just kind of absorb and
amplify the biases that we already have.
[Participant ID # 10].
It was also a concern that datasets used for AI may
have selection bias, meaning participants that are not
representative of the population as a whole. They also
noted that there may have been inadequate attention
paid to this issue when applying AI.
Definitely [traditional epidemiological] studies have
the potential for those biases, although we do a lot
to try and minimize them or at least them and quan-
tify the impact. And so, I think the difference is we’re
not talking about this with AI. I haven’t seen any dis-
cussion of oh, we should quantify the impact of the se-
lection bias in our, you know, neural network. Or I’ve
seen much less of that.
[Participant ID # 12].
Furthermore, it was pointed out that much of the
data used with AI is generated as a by-product or for
purposes unrelated to proposed applications. This can
make it more difficult to understand potential biases
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and errors in measurement of variables of interest
(see Additional file 6). Despite these concerns, some
interviewees pointed out the potential for AI to re-
move bias from judgments.
… [AI] removes that human element, which in some
ways is quite good [even though] some people don’t
like it. I think there’s a huge benefit of having that
human element and that potential bias removed
from the […] actual actions.
[Participant ID # 9].
It was suggested that AI approaches could be
trained to reduce bias, and that while bias is a risk it
could be overcome with more research (see Add-
itional file 6).
I think it’s easy for people to say well that data is
garbage and that is garbage. I think we need to get
more nuanced to say when, what measurement
error counts when and where?
[Participant ID # 12].
Uncertain impact on inequity
Respondents were worried that the use of AI and novel
complex data sources to better target interventions in
public health (sometimes referred to as precision public
health) [25] could worsen health inequity, both within
and between countries, based on ability to afford the ne-
cessary technologies.
… one of the huge concerns that I have around
so-called precision medicine, precision public
health, is it just strikes me that these are inherently
inequity exacerbating […] for a variety of reasons. […]
Who’s gonna be within a health system that’s got the
capacity to develop these things and produce
products that are used for … You know, it ain’t
going to be low- middle-income countries. It’s
going to be high-income countries and it’s going
to be specific communities, you know, entities,
economic strata, within that.
[Participant ID # 1].
Furthermore, there is the potential for selection bias in
the data used for AI applications to further marginalize
underrepresented populations (see Additional file 6).
[If your data is not representative of the population]
you could be, you know, making things worse,
consistently, systematically, for people in terms of
what you’re recommending or detecting or not
detecting.
[Participant ID # 3]
However, others proposed that the increased health in-
formation and service-accessibility enabled by AI may in
fact reduce inequities.
… we know that better-educated, higher-income
people tend to have healthier diets and access to
better information […] So, [we may reduce inequity]
if we’re able to create better personalized tools, […]
like a voice interface that can give someone with a
low reading level access to good nutritional information.
[Participant ID # 7].
Hold the hype
Despite major advances, interviewees believed that AI is
shrouded in hype, and that this could lead to it taking
resources away from proven approaches.
That whole concept that, you know, this is what’s
new, this is what’s getting hyped, this is what’s
absolutely sexy and is starting to suck in policy-
makers, funders, etcetera. To the point where we
take from where we should be investing because
the historical track record indicates that it has
produced good.
[Participant ID # 1].
They stressed that it is not so different from traditional
statistical methods and is subject to similar limitations,
which is often not fully appreciated.
You can think of AI as just […] the next set of tools
in statistics. Yeah, we moved beyond t-tests and we
have convolutional neural networks now but the
basic principles […] are fundamentally the same …
[Participant ID # 4].
As such, participants thought that it should be empha-
sized that concerns regarding issues like bias apply equally
to AI applications, as they always have in statistical appli-
cations to public health. It was posited that AI researchers
have been mostly focused on developing advanced
methods, while data generation and potential bias has
been of less concern, leading to some of this confusion.
[The computer science] discipline has been fo-
cused on developing the method, not generating
the data. So, and that’s not a criticism, that’s just
what they do, and it’s great that they do. But
when you’re in public health […] you have to
focus on […] generating that data or understand-
ing the pros and cons of different data for a pub-
lic health application. We spend a lot of time,
actually more time, on the dataset, data creation, data
analysis, […] data interpretation, data integration than
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[Participant ID # 12]
Experts indicated that AI has been most impactful so far in
commercial efforts, such as sales and marketing, where there
is often higher tolerance for errors than in public health.
[A soda company brand] can maybe afford some level
of error […] in what a machine spits out when it’s
doing a marketing campaign to sell more [beverages.]
[….] We don’t have that same luxury […] where we’re
dealing with human life and human health. And so, I
think that’s going to be a struggle for us because we’re
going to need to have that higher threshold of accur-
acy and more confidence that [the] machine-created
algorithm is going to be acceptable.
[Participant ID # 2]
There is also a concern that AI-based errors could be
even more damaging than those of poorly performing
human public health practitioners or doctors.
… if it were just one doctor making a mistake, then
that is fine, […] I mean that’s not fine, but at least
only one patient is harmed. But if an AI makes a
mistake, then potentially tens of thousands of pa-
tients will […] be harmed.
[Participant ID # 13].
Rigorous regulation required
Several respondents were concerned about the largely
unregulated nature of AI and its use in public health.
… a lot of these tech groups operate under the same
ethos that, [various companies in Silicon Valley do],
which is ‘move fast and break things’. […] And, in
[health], when you move fast and break things, lives are
at risk. And so, a worry of mine is that some of these
AI groups are going to potentially move too quickly.
[Participant ID # 14].
As such, most participants agreed that rigorous regula-
tion is necessary. However, they were unsure of exactly
what form this should take.
So, somehow, we almost need like [a Food and
Drug Administration] for artificial intelligence,
that will regulate constant evaluation of the AI
tools that we are incorporating into practice.
[Participant ID # 13].
Discussion
Our findings from this qualitative study can serve as a
preliminary roadmap of high-level issues for decision-
making about AI in public health. Our results also
support investigating multiple applications of AI, broadly
including using AI to gain better insights from data and
to develop improved public health interventions.
New or improved information gathering
Participants were optimistic about the potential for AI-
based applications to incorporate different types of unstruc-
tured data into disease surveillance, to do this in a more
continuous and timely fashion, and to better leverage large,
linked databases. Existing examples highlighted by partici-
pants include using natural language processing to analyze
emergency room triage data in real-time for anomalies,
monitoring social media and news reports for emerging
infectious diseases worldwide [11], and using ontologies to
integrate public health-relevant data from numerous
sources and identify evidence-informed intervention
recommendations (e.g. PopHR) [26]. Another real-world
example is the use of individual-level online search data to
identify foodborne illness and prioritize restaurant inspec-
tions, which may be superior to traditional approaches [27].
More recently, BlueDot, a private company, used ap-
proaches similar to HealthMap (but also integrating propri-
etary airline ticketing data) to identify the Covid-19
outbreak before the World Health Organization [28], and
was similarly successful in predicting the spread of Zika
virus [29]. Our findings are consistent with an evolution of
opportunities previously identified in public health inform-
atics, which has progressed to integrating increasing
amounts of data with less latency, permitting timelier action
[30]. While promising, the identified applications using AI
to leverage big data have yet to be widely used in practice,
and further research is needed to assess their effectiveness
and feasibility compared to existing approaches. Further-
more, most suggested applications would only complement
existing public health indicators. Given that AI may enable
entirely new approaches in public health, ongoing creative
thinking could help to maximize its benefits. In particular,
the combination of AI and big data may allow novel and
more precise characterizations of the social determinants
and their impacts on health [17].
New or improved public health interventions
Opportunities for improved public health interventions
were also outlined, such as automated and novel forms
of screening for diseases, adaptive and personalized
health promotion, and leveraging social networks for
health promotion. As suggested by participants, certain
forms of screening, including for cervical precancer, can
already be performed with greater accuracy using AI
[31]. Novel forms of screening have also begun, such as
using machine learning to screen for atrial fibrillation
with Apple watches, which was recently approved by the
FDA [32]. However, unless such devices were proven to
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be cost-effective and ethical, they are unlikely to be use-
ful in public health practice. Other expert suggestions
included using AI to inform health promotion interven-
tions in real-time, such as using transaction data to in-
form vegetable signage placement in grocery stores. This
would be a type of “nudge”, or intervention that tailors
the presentation of information to encourage beneficial
behaviours [33]. Early systematic reviews demonstrate
efficacy of such interventions in certain contexts [34];
however, there are ethical concerns regarding their use
[33] and few thus far have used AI. The potential for
using social media and more targeted health promotion
approaches, some of which apply AI, appears promising
in early reviews [35–37]. For example, AI-based chatbots
have been used successfully as weight-loss coaches and
to deliver cognitive behavioural therapy [38, 39]. Lastly,
experts mentioned the potential for AI to leverage social
network structure to increase the effectiveness of health
promotion interventions. There is initial work in this
area, including a group in California developing RE-
CONNECT, an algorithm that connects individuals with
friends who are likely to increase the chance of positive
behaviour change [40]. Overall, the potential for AI to
improve public health interventions is promising, as sug-
gested by experts, but similarly to the use of AI for ana-
lyzing big data, these tools have rarely been incorporated
in practice and need further study.
Role in inference and prediction
Respondents offered somewhat divergent views regard-
ing AI’s role in causal inference and prediction, which
both inform public health practice. Causal inference in
epidemiology is necessary for evidence-informed public
health interventions. For example, Sir Austin Bradford
Hill’s causal criteria were used to inform identification
of the causal link between smoking and lung cancer,
which has led to decades of successful preventive inter-
ventions [41]. An initial step towards causal inference is
hypothesis generation, which machine learning algorithms
such as random forest can contribute to by identifying
“important” variables for predicting specific health out-
comes in training datasets [42]. While AI has had limited
use in more formal causal analysis, it is now being used
for this purpose in targeted learning, an alternative that
may outperform propensity score methods [43]. Outside
of the specific algorithms that can be used for exploratory
analyses and targeted learning, there seems to be limited
applicability of AI for inference. However, as identified by
participants, this is a very active area of research with new
methods for interpreting algorithms under development
[44]. Predictive algorithms can also inform public health
practice by anticipating future disease burdens, directing
policy, and targeting preventive interventions towards the
highest-risk groups. For example, population-level
predictive models have been developed to inform policy
around dementia, diabetes, and cardiovascular diseases
[45–47]. Despite substantial optimism about AI-based
prediction, recent systematic reviews found no improve-
ment in machine learning-based clinical prediction
models generally [48], or for chronic diseases [49], when
compared to logistic regression. However, it was acknowl-
edged that most models only incorporated a small number
of simple predictors, which might not fully leverage ma-
chine learning methods. Furthermore, a scoping review of
machine learning-based prediction applications in popula-
tion health found infrequent use of novel and large data
sources, which may have hindered their performance [50].
Additionally, there was limited adherence to guidelines,
which makes robust comparisons challenging. Overall, ex-
perts were divided on the utility of AI for inference in
public health, with some stating that it would be unlikely
to help identify novel risk factors. More fundamental re-
search into methods development will be necessary to
clarify AI’s applicability to causal inference. In the mean-
time, further studies applying amenable AI methods [16]
to exploratory analyses in public health could help ascer-
tain its utility for risk factor discovery. Finally, additional
studies comparing machine learning approaches to trad-
itional methods for prediction that use big data and ad-
here to guidelines are necessary to further clarify when AI
might offer improvements.
Barriers: capacity and data
Barriers to the adoption of AI in public health must be
addressed before useful applications can be widely
deployed. Key issues identified were a lack of leadership,
available expertise, and funding to pursue AI ap-
proaches. Experts suggested that teaching high-level ma-
chine learning concepts to public health practitioners
could be helpful in catalyzing AI initiatives. Interestingly,
such an initiative has begun in Canada, scheduled to
start in the summer of 2021 [51]. Stakeholders could
also consider targeted funding for development of AI
initiatives in public health, including programs for dual-
trained AI and public health practitioners who can work
productively with AI experts. Another concern is limited
access to high-quality data. Experts highlighted numer-
ous data sources of interest to public health, such as
electronic medical records, administrative databases,
health surveys, social media, and news reports with
widely differing formats and standards. The lack of
standardization (e.g. widely differing EMR software) and
inconsistencies in data entry (e.g. in free-form clinical
notes) make linkage of datasets and deployment of AI
methods challenging [52]. This could be alleviated by
adopting common data standards, alongside legislation
that supports greater integration and access to relevant
data. An initiative addressing some of these issues is
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underway in Canada, the Strategy for Patient-Oriented
Research (SPOR), which aims to accelerate efforts to
harmonize, link, and reduce barriers to access for a var-
iety of governmental health and social datasets [53]. The
adoption of standard EMRs and public health informa-
tion systems across jurisdictions, that also encourage
machine-readable data entry, would be an additional
helpful strategy. Another issue noted by experts is the
difficulty in accessing proprietary data that would be
useful for public health, such as wearable or grocery
transaction data. The success of BlueDot’s disease sur-
veillance initiatives [28], using private airline data, and
FINDER’s foodborne illness tracing [27], which involved
a partnership with Google, suggest the feasibility and
value of pursuing public-private partnerships. Relevant
retail transaction data has also been integrated into
PopHR [26]. Such partnerships could be accelerated with
greater financial and research investment. Similar
barriers related to overall capacity and data quality have
been previously highlighted by public health informati-
cians, who have had some success developing interdiscip-
linary training programs and improving data integration
[54]. This is encouraging for future deployment of AI in
public health. Finally, as noted by experts, privacy con-
cerns can prevent access to important public health data
and must be addressed. It was suggested that the public
might be more supportive than anticipated of public
health’s use of their data, which is supported by initial
studies [55–57]. Future research should continue to evalu-
ate the public’s appetite for use of their data for public
health applications in local contexts and develop best
practices for the use of novel data sources. Policymakers
and practitioners should follow these developments to
inform improvements in data infrastructures and surveil-
lance systems.
Bias and impact on health equity
Many risks surrounding AI remain to be overcome.
Experts were concerned about propagation of societal
and cognitive biases, as well as intensification of infor-
mation and selection bias. For example, racial bias was
recently found in an AI algorithm designed to help guide
referrals and future healthcare decisions [58]. The algo-
rithm was biased towards predicting lower health needs
for Black patients, because it used healthcare costs as a
proxy for need. Less money had been spent on Black pa-
tients with the same level of need in its training data.
Left unchecked, similar biases could lead to inappropri-
ate allocation of services and preventive interventions in
a public health setting. Furthermore, selection bias can
have an impact when groups are not included in training
data, resulting in suboptimal performance. This was
highlighted recently among cardiovascular prediction
models trained almost exclusively on White people [59].
Finally, measurement error can reduce the accuracy of
AI models, as was seen with Google Flu Trends when
changes in Google’s search algorithms and spurious
media events changed what their algorithms were meas-
uring [60]. Efforts to reduce the effects of these biases
on AI applications include the adoption of big data stan-
dards, the use of algorithms to detect and eliminate bias,
and greater efforts to be inclusive of the population as a
whole during data collection [61]. Ongoing research is
needed to improve understanding of the effects of these
biases, implement strategies to adapt to their presence,
and ascertain the suitability of new data-sources for use
in public health. Furthermore, AI’s effects on inequities
must also be evaluated continually. Ideally, as suggested
by participants, AI investments should focus on areas
likely to reduce inequities, including improved access to
public health services and health information. This could
include examples previously identified, such as an auto-
mated weight-loss coach [38] and the use of novel data
sources to expand disease surveillance globally [11].
Hype and regulation
Experts were concerned about hype surrounding AI. In
addition to statistical limitations, they noted that the im-
plementation of AI in public health will be more difficult
than in industry, where the stakes are often lower. Con-
sequently, the limitations of AI in public health contexts
should be emphasized during related training. Further-
more, given a lack of evidence from implementation of
AI in public health, it is uncertain to what degree AI
techniques might improve upon public health actions
that are already heavily data informed. Keeping these
caveats in mind, it is essential that practitioners not
significantly disinvest from traditional public health
practice in their enthusiasm to adopt AI.
Our findings suggest that AI should be regulated; how-
ever, further work is needed to determine how and by
whom. The Federal Drug Administration has recently
proposed a regulatory framework for AI-based software
as a medical device, that would uniquely permit continuous
improvement and learning of approved algorithms [62].
While primarily aimed at healthcare, this is an important
step that will inform regulation in public health. There is
also a need for practice guidelines for the use of AI tools to
inform both regulators and public health decision-makers.
The GRADE approach to guideline development, particu-
larly Evidence to Decision (EtD) frameworks [63], could be
useful for systematically and transparently appraising not
only the health benefits and harms of AI tools but also key
considerations in the evaluation of AI including cost-
effectiveness, equity, acceptability, and feasibility [64]. By
applying the EtD framework to public health guidance
around the use of AI, we could increase the chance that AI
interventions truly have a net benefit to population health.
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The application of EtD frameworks would be based on
additional work to identify best practices in the use of AI
methods in health research. Finally, stakeholders must col-
lectively decide which organizations would use these guide-
lines to regulate the use of AI in public health.
Disruptive innovation
Viewing AI as a disruptive technology, our findings are
consistent with disruptive innovation theory [65]. This
theory describes a propensity for new technologies to
take root in either market-segments that are over-served
by mainstream performance capabilities or new markets
made possible by innovations. Eventually, an innova-
tion’s performance may improve to a point where it can
serve mainstream needs. For example, personal com-
puters were a disruptive technology that opened a new
market by providing a lower-cost, lower-performance al-
ternative to mainframe computers and minicomputers
[66]. Eventually, their performance improved to the
point that they could meet almost all market-segment
needs. While applications of the disruptive innovation
theory outside of private industry are imperfect, our
findings highlight initial opportunities for AI in public
health that are analogous to new markets [67], such as
novel forms of disease surveillance and health promo-
tion. These activities were previously impossible because
leveraging big and unstructured data in real-time is not
feasible for humans and standard statistical approaches.
Therefore, these “new market” applications may be
among the first widely used AI tools in public health.
Conversely, respondents characterized core public health
activities as requiring high-performance, including min-
imal bias, attention to health equity, and high accuracy,
due to the sector’s impact on people’s health. These
requirements explain experts’ concern about hype and
predict that core public health will be more difficult to
disrupt than the mainstream of other markets. For
example, market segments interested in activities like
targeted advertising of consumer products and movie
recommendations may find that their needs are already
met by the performance levels of current AI tools. The
disruptive innovation perspective also suggests that public
health organizations may be able to accelerate adoption of
AI by establishing semi-autonomous innovation units
[66]. This is analogous to the approach taken by the city
of Chicago with their Department of Innovation and
Technology, which helped the city’s public health depart-
ment become a leader in the application of AI [68]. In
jurisdictions without sufficient resources to consider this
at the local or regional-level, such a strategy could be con-
sidered by state/provincial or national bodies. In the near-
term, AI is likely to be restricted to use in new (previously
impossible) public health domains with strict oversight.
As AI’s performance improves, it may be applied to pro-
gressively more core public health needs.
Strengths and limitations
To our knowledge, this is the first study to systematically
and broadly assess experts’ appraisal of the implications
of AI for public health practice. We used a credible
qualitative study design that revealed diverse perspec-
tives from multiple disciplines, countries, and settings.
Our study was limited by a small sample size and non-
probability sampling. Therefore, in the context of the broad
area of inquiry, our results are unlikely to capture all pos-
sible implications of AI for public health practice. However,
this was not our intention. Additionally, our sample had a
smaller number of female participants, which may reflect a
lack of diversity in AI-research and industry [69]. We also
recruited relatively few AI-focused researchers. Given that
all invitees who refused to participate were in the AI field,
this may reflect the lack of capacity identified in our study.
Conclusions
Our results highlight that AI holds promise for improving
public health practice; however, many barriers remain,
and risks need to be better characterized. Experts empha-
sized the potential for AI to improve disease surveillance
and health promotion interventions, which should be the
focus of further research and evaluative studies. To suc-
cessfully implement AI, initiatives increasing AI expertise
and funding for public health are necessary. Public health
policy innovations should improve the standardization, in-
tegration, and availability of relevant high-quality data.
Further research is also needed to determine the best use-
cases of AI, how to mitigate bias, and how to ensure a
positive impact on health equity. In the meantime, train-
ing initiatives for AI-practitioners in public health should
emphasize the limitations of AI, in order to combat hype.
Finally, ongoing research and collaboration is needed to
better regulate AI, steering it towards truly benefiting
population health. As one respondent phrased it: “AI’s
gonna have an impact on everything in society, so it has to
have an impact on public health”. As this impact comes, it
is up to the public health community whether we will be
ahead of, or behind, the curve.
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